Sort
46,585 grants matching “heart failure”
Targeting trained immunity in transplantation
$3,012,041Zahi A. Fayad · Icahn School Of Medicine At Mount Sinai · P01 · FY2023 · AI
Targeting trained immunity in transplantation
$3,010,650Zahi A. Fayad · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · AI
CARDIOVASCULAR GENE THERAPY CENTER
$3,009,199University Of Pittsburgh At Pittsburgh · U01 · FY2000 · HL
Genetic contributors to diabetes and dyslipidemia in African Americans
$3,008,855Michele M Sale · University Of Virginia · R01 · FY2009 · DK
Small blood pumps for small patients
$3,007,461Trevor Arnoult Snyder · Vadovations, Inc. · R44 · FY2017 · HL
Small blood pumps for small patients
$3,007,461Trevor Arnoult Snyder · Vadovations, Inc. · R44 · FY2015 · HL
Nonclinical Studies to Advance Novel Drug for Post-STEMI Cardiac Regeneration
$3,000,000Hynda Karen Kleinman · Regenerx Biopharmaceuticals, Inc. · RC3 · FY2010 · HL
Rare variants and NHLBI traits in deeply phenotyped cohorts
$3,000,000Bruce M Psaty · University Of Washington · R01 · FY2016 · HL
IGF::OT::IGF SBIR Topic 094, Direct to Phase II, Transcatheter Cavopulmonary Bypass Endograft IGF::OT::IGF
$2,999,984Nasser Rafiee · Transmural Systems, Llc · N44 · FY2016 · HL
Targeted DOK7 gene therapy for Congenital Myasthenic Syndromes
$2,999,358Patricio Sepulveda · Amplo Biotechnology, Inc. · R44 · FY2024 · NS
Safety and Efficacy of Allogeneic Cardiosphere-derived Stem Cells After MI
$2,993,268Rachel Ruckdeschel Smith · Capricor, Inc. · RC3 · FY2010 · HL
PROMISE Trial: Clinical Coordinating Center
$2,980,313Pamela Susan Douglas · Duke University · R01 · FY2012 · HL
Discovery and Development of Therapeutic Genes for CHF
$2,976,411H. Kirk Hammond · Veterans Medical Research Fdn/San Diego · P01 · FY2016 · HL
Discovery and Development of Therapeutic Genes for CHF
$2,974,646H. Kirk Hammond · Veterans Medical Research Fdn/San Diego · P01 · FY2017 · HL
Discovery and Development of Therapeutic Genes for CHF
$2,972,180H. Kirk Hammond · Veterans Medical Research Fdn/San Diego · P01 · FY2013 · HL
Alabama-Clinical Trials Unit
$2,969,781Michael S. Saag · University Of Alabama At Birmingham · U01 · FY2011 · AI
Framingham Project/Levy
$2,962,311Daniel Levy · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments
$2,958,258Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
UC BRAID Center for Accelerated Innovation
$2,957,509Michael J Palazzolo · University Of California Los Angeles · U54 · FY2015 · HL
Pre-Clinical and Clinical Evaluation of Skeletal Muscle Activator, CK-2017357 for
$2,948,895Fady Malik · Cytokinetics, Inc. · RC3 · FY2010 · NS
Genomic Predictors of Arteriosclerosis in Hypertensives
$2,944,328Sharon L Kardia · University Of Michigan At Ann Arbor · R01 · FY2007 · HL
Mitigating risk in a closed loop system by exercise detection and miniaturization
$2,943,303Peter G Jacobs · Oregon Health & Science University · DP3 · FY2013 · DK
Healthy Aging In Neighborhoods of Diversity Across the Life Span (HANDLS)
$2,938,466Michele K Evans · National Institute On Aging · Z01 · FY2008 · AG
Discovery and Development of Therapeutic Genes for CHF
$2,932,664H. Kirk Hammond · Veterans Medical Research Fdn/San Diego · P01 · FY2015 · HL
Main Administrative Core
$2,927,614Anne M Murray · Hennepin Healthcare Research Institute · U19 · FY2023 · AG